Form 10-Q Ocata Therapeutics, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil up around 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Ocata Therapeutics (OCAT) Reports Q3 Loss Per Share of $0.09
November 9, 2015 9:00 AM ESTOcata Therapeutics (NASDAQ: OCAT) reported Q3 EPS of ($0.09), versus ($0.13) reported last year.
For earnings history and earnings-related data on Ocata Therapeutics (OCAT) click here.
... More
